Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Porin A subtype P1.4, often referred to as PorA P1.4, is a subtype of the major outer membrane porin (PorA) found in *Neisseria meningitidis* serogroup B and is recognized as a key antigen involved in meningococcal disease outbreaks in Western countries[1][5]. PorA is a trimeric β-barrel protein that forms pores in the bacterial outer membrane, allowing passive diffusion of small hydrophilic compounds[2][3][5]. The P1.4 designation refers to a specific variant defined by the sequence of surface-exposed loop regions (especially loop 1 and 4), which are highly immunogenic and serve as the primary target for subtype-specific bactericidal antibodies[1][5]. Vaccines based on PorA P1.4-derived peptides or outer membrane vesicles primarily induce protective antibody responses through recognition of these loops, although antigenic diversity among PorA subtypes remains a challenge for universal vaccine efficacy[1][5].
For vaccines and antibodies: recognition of the surface-exposed loop regions by the adaptive immune system, leading to antibody-mediated complement activation and bacterial lysis
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Porin A protein subtype P1.4 (PorA P1.4).